Financials AirSculpt Technologies, Inc.

Equities

AIRS

US0094961002

Healthcare Facilities & Services

Market Closed - Nasdaq 21:00:00 25/06/2024 BST 5-day change 1st Jan Change
3.93 USD +0.51% Intraday chart for AirSculpt Technologies, Inc. -2.00% -47.53%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 956.5 207.8 429.6 226.2 - -
Enterprise Value (EV) 1 1,014 281.8 491 275.1 247.5 214.4
P/E ratio 90.7 x -14.2 x -93.6 x 16.2 x 12.3 x 9.28 x
Yield - - - - - -
Capitalization / Revenue 7.17 x 1.23 x 2.19 x 1.09 x 0.93 x 0.83 x
EV / Revenue 7.6 x 1.67 x 2.51 x 1.32 x 1.02 x 0.79 x
EV / EBITDA 22 x 6.52 x 11.4 x 6.63 x 4.62 x 3.43 x
EV / FCF 51.9 x 24.4 x 35 x 25.2 x 10.4 x 6.95 x
FCF Yield 1.93% 4.09% 2.86% 3.96% 9.61% 14.4%
Price to Book 11.5 x 2.94 x - - - -
Nbr of stocks (in thousands) 55,640 56,172 57,356 57,570 - -
Reference price 2 17.19 3.700 7.490 3.930 3.930 3.930
Announcement Date 11/03/22 10/03/23 27/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 62.77 133.3 168.8 195.9 208.2 243.7 272
EBITDA 1 - 46.11 43.19 43.24 41.5 53.61 62.49
EBIT 1 10.03 39.51 35.13 - 28.34 25.66 32.71
Operating Margin 15.98% 29.64% 20.81% - 13.61% 10.53% 12.03%
Earnings before Tax (EBT) 1 7.577 10.88 -11.3 2.998 21.4 23.58 31.96
Net income 1 - 10.55 -14.68 -4.479 14.17 19.03 25.36
Net margin - 7.91% -8.7% -2.29% 6.81% 7.81% 9.32%
EPS 2 - 0.1896 -0.2600 -0.0800 0.2433 0.3200 0.4233
Free Cash Flow 1 - 19.52 11.53 14.04 10.91 23.8 30.87
FCF margin - 14.64% 6.83% 7.16% 5.24% 9.76% 11.35%
FCF Conversion (EBITDA) - 42.33% 26.69% 32.47% 26.28% 44.38% 49.4%
FCF Conversion (Net income) - 184.98% - - 76.96% 125.05% 121.72%
Dividend per Share - - - - - - -
Announcement Date 06/07/21 11/03/22 10/03/23 27/02/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 37.56 39.54 49.65 38.89 40.7 45.81 55.7 46.79 47.61 47.62 55.06 49.89 55.72 55.18 65.25
EBITDA 1 10.21 9.788 15.23 9.174 8.998 10.72 14.61 9.075 10.09 7.337 11.8 10.03 12.34 11.12 15.03
EBIT 1 8.279 -1.171 - - - - - - - - 4.805 4.853 7.669 4.01 6.69
Operating Margin 22.04% -2.96% - - - - - - - - 8.73% 9.73% 13.76% 7.27% 10.25%
Earnings before Tax (EBT) 1 -13.82 -2.663 2.404 -3.145 -7.892 0.027 3.471 -0.881 0.381 9.48 4.341 2.685 4.894 3.65 7.458
Net income 1 -14.15 -0.693 0.583 -7.377 -7.192 -0.014 1.776 -1.667 -4.574 6.029 2.183 1.78 4.189 2.4 5.844
Net margin -37.68% -1.75% 1.17% -18.97% -17.67% -0.03% 3.19% -3.56% -9.61% 12.66% 3.97% 3.57% 7.52% 4.35% 8.96%
EPS 2 -0.3500 -0.0100 0.0100 -0.1300 -0.1300 - 0.0300 -0.0300 -0.0800 0.1000 0.0400 0.0300 0.0700 0.0400 0.0967
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/03/22 13/05/22 12/08/22 10/11/22 10/03/23 12/05/23 11/08/23 09/11/23 27/02/24 10/05/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 57.3 73.9 61.4 48.9 21.3 -
Net Cash position 1 - - - - - - 11.8
Leverage (Debt/EBITDA) - 1.242 x 1.712 x 1.419 x 1.178 x 0.3973 x -
Free Cash Flow 1 - 19.5 11.5 14 10.9 23.8 30.9
ROE (net income / shareholders' equity) - 32.4% 28.1% - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - 1.500 1.260 - - - -
Cash Flow per Share - - - - - - -
Capex 1 - 7.12 12.9 9.92 16.1 10.5 10.5
Capex / Sales - 5.34% 7.65% 5.06% 7.74% 4.31% 3.86%
Announcement Date 06/07/21 11/03/22 10/03/23 27/02/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
3.93 USD
Average target price
5 USD
Spread / Average Target
+27.23%
Consensus
  1. Stock Market
  2. Equities
  3. AIRS Stock
  4. Financials AirSculpt Technologies, Inc.